longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Japan’s FY26 price revision expands G1 repricing and drives price reduction

Pharmaceutical Technology
May 8, 2026 at 03:59 PM

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

Login to unlock221characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Sep 8, 2026 at 12:14 PMAI-era DCI: Beyond the chip, compete as a network. Is there a China play?
  • Apr 23, 2026 at 10:32 PMReminder: Focus on Intraday Events Today (All Times in Beijing Time)
  • Apr 22, 2026 at 03:23 AM"Betting on Yen Stabilization + Diminishing War Impact": US Investors Return to Japanese Stock Market
  • Apr 20, 2026 at 11:25 AMMarket Has 'Abandoned April Rate Hike'; Bank of Japan Turns to Wait-and-See: Is the Real Window in June?
  • Apr 16, 2026 at 11:22 PMExpectations of Extended US-Iran Ceasefire Boost Asia-Pacific Markets; Japanese Stocks Hit Record Highs, Taiwan Market C…

Related Stocks

CSOP NIKKEI225

CSOP NIKKEI225

HK03153

Huaan MUFG N225 ETF(QDII)

Huaan MUFG N225 ETF(QDII)

SH513880

ChinaAMC Nomura N225 ETF(QDII)

ChinaAMC Nomura N225 ETF(QDII)

SH513520

LongbridgeAI